{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:13:51Z","timestamp":1789726431872,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00415-014-7334-7","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T15:03:45Z","timestamp":1397574225000},"page":"1203-1209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Increased \u03b1-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease"],"prefix":"10.1007","volume":"261","author":[{"given":"Takashi","family":"Kasai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M. A.","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,16]]},"reference":[{"key":"7334_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000107082","volume":"24","author":"K Satoh","year":"2007","unstructured":"Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K (2007) Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt\u2013Jakob disease. Dement Geriatr Cogn Disord 24:207\u2013212","journal-title":"Dement Geriatr Cogn Disord"},{"key":"7334_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","volume":"79","author":"C Hamlin","year":"2012","unstructured":"Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, Spear C, Bizzi A, Debanne SM, Rowland DY (2012) A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 79:547\u2013552. doi: 10.1212\/WNL.0b013e318263565f","journal-title":"Neurology"},{"key":"7334_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0166-2236(91)90105-4","volume":"14","author":"M Goedert","year":"1991","unstructured":"Goedert M, Crowther RA, Garner CC (1991) Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci 14:193\u2013199","journal-title":"Trends Neurosci"},{"key":"7334_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-007-0565-5","volume":"332","author":"JG Fournier","year":"2008","unstructured":"Fournier JG (2008) Cellular prion protein electron microscopy: attempts\/limits and clues to a synaptic trait. Implications in neurodegeneration process. Cell Tissue Res 332:1\u201311. doi: 10.1007\/s00441-007-0565-5","journal-title":"Cell Tissue Res"},{"key":"7334_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00001756-199301000-00017","volume":"4","author":"J Clinton","year":"1993","unstructured":"Clinton J, Forsyth C, Royston MC, Roberts GW (1993) Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport 4:65\u201368","journal-title":"Neuroreport"},{"key":"7334_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2990.2000.00216.x","volume":"26","author":"M Jeffrey","year":"2000","unstructured":"Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, Sayers AR, Brown DA, Fraser JR (2000) Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26:41\u201354","journal-title":"Neuropathol Appl Neurobiol"},{"key":"7334_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM (2006) Decreased \u03b1-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun 349:162\u2013166","journal-title":"Biochem Biophys Res Commun"},{"key":"7334_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and \u03b1-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726. doi: 10.1093\/brain\/awq008","journal-title":"Brain"},{"key":"7334_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, Schlossmacher MG (2008) Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213:315\u2013325. doi: 10.1016\/j.expneurol.2008.06.004","journal-title":"Exp Neurol"},{"key":"7334_CR10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240. doi: 10.1016\/S1474-4422(11)70014-X","journal-title":"Lancet Neurol"},{"key":"7334_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12013-007-0014-9","volume":"47","author":"K Beyer","year":"2007","unstructured":"Beyer K (2007) Mechanistic aspects of Parkinson\u2019s disease: \u03b1-synuclein and the biomembrane. Cell Biochem Biophys 47:285\u2013299","journal-title":"Cell Biochem Biophys"},{"key":"7334_CR12","unstructured":"Zeidler M, Gibbs CJ Jr, Meslin F (1998) WHO mannual for strengthening diagnosis and surveillance of Creuzfeldt-Jakob disease. World Health Organization, Geneva, pp 47\u201351"},{"key":"7334_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/mf.1998.20.3.485673","volume":"20","author":"T Nishimura","year":"1998","unstructured":"Nishimura T, Takeda M, Nakamura Y, Yosbida Y, Arai H, Sasaki H, Shouji M, Hirai S, Khise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Urakami K, Adachi Y, Nakashima K, Toji H, Nakamura S, Yoshida H (1998) Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer\u2019s disease and related disorders: multicenter study in Japan. Methods Find Exp Clin Pharmacol 20:227\u2013235","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"7334_CR14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OM El-Agnaf","year":"2003","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) \u03b1-Synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J 17:1945\u20131947","journal-title":"FASEB J"},{"key":"7334_CR15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R et al (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38:643\u2013648","journal-title":"Ann Neurol"},{"key":"7334_CR16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2011.08.003","volume":"45","author":"PG Foulds","year":"2012","unstructured":"Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid \u03b1-synuclein levels are raised in multiple system atrophy and distinguish this from the other \u03b1-synucleinopathies, Parkinson\u2019s disease and Dementia with Lewy bodies. Neurobiol Dis 45:188\u2013195. doi: 10.1016\/j.nbd.2011.08.003","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7334-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7334-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T04:15:35Z","timestamp":1689135335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,16]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["7334"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7334-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,16]]}}}